Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PTCT PTC Therapeutics > Main Composition
PTCT PTC Therapeutics
42.060
+0.510+1.23%
Post Mkt Price
42.0600.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Net product revenue--428.9M79.63%
Collaboration revenue--55.05M10.22%
Royalty revenue--54.64M10.15%
Region Unit:USD
nameYOYOperating income%
United States--297.01M55.14%
Non-US--241.59M44.86%
Company Overview More
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
CEO: Dr. Stuart W. Peltz, PhD
Market: NASDAQ
Listing Date: 06/20/2013
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist